Specifically, 67% of breast carcinoma cell lines, 77% of colorectal carcinoma cell lines, 60% of pancreatic carcinoma cell lines, 77% of endometrial carcinoma cell lines, and 100% of head/neck carcinoma cell lines expressed elevated levels of E-cad. The gene discussed is CDH1; the disease is colorectal carcinoma.